Yahoo Finance Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Aerie Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / October 15, 2018 / U.S. markets bounced on Friday, erasing some of the losses for the week, as the third quarter earnings season kicked off. The Dow Jones Industrial Average jumped 1.15 percent to close at 25,339.99, while the S&P 500 Index increased 1.42 percent to close at 2,767.13. The Nasdaq Composite Index closed up 2.29 percent to close at 7,496.89.
According to Michael Arone, chief investment strategist for State Street Global Advisors, “Solid earnings helped investors breath a sign of relief.” Arone also said, “That gains accelerated towards the close indicates that investors are confident about the economy.”
RDI Initiates Coverage on:
GW Pharmaceuticals plc
https://rdinvesting.com/news/?ticker=GWPH
Aerie Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=AERI
GW Pharmaceuticals’ stock moved 1.67% higher Friday, to close the day at $143.32. The stock recorded a trading volume of 462,409 shares, which was below its three months average volume of 505,862 shares. In the last year, GW Pharmaceuticals' shares have traded in a range of 101.07 - 179.65. The share price has gained 41.8% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $151.55 is above its 200-day moving average of $143.29. Shares of GW Pharmaceuticals have gained roughly 1.52 percent in the past month and are up 8.57 percent year-to-date.
Access RDI's GW Pharmaceuticals plc Research Report at:
https://rdinvesting.com/news/?ticker=GWPH
On Friday, shares of Aerie Pharmaceuticals recorded a trading volume of 491,335 shares, which was above the three months average volume of 413,884 shares. The stock ended the day 5.35% higher at $55.37. The share price has fallen 25.93% from its 52 week high with a 52 week trading range of 47.06 - 74.75. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $58.33 is below its 200-day moving average of $59.67. Shares of Aerie Pharmaceuticals have fallen roughly 6.39 percent in the past month and are down 7.33 percent year-to-date.
Access RDI's Aerie Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AERI
Our Actionable Research on GW Pharmaceuticals plc (NASDAQ:GWPH) and Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
